Protective effects of ONO-5046·Na, a specific neutrophil elastase inhibitor, on postperfusion lung injury

Annals of Thoracic Surgery

Volumn 68, Issue 6, 1999, Pages 2141-2146

  Yamazaki, Takenori ^a   Ooshima, Hideki ^a   Usui, Akihiko ^a   Watanabe, Takashi ^a   Yasuura, Kenzo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SIVELESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; DRUG EFFECT; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME INHIBITION; HISTOLOGY; LUNG FUNCTION; LUNG INJURY; LUNG PERFUSION; NONHUMAN; PRIORITY JOURNAL; PROTECTION;

ANIMALS; CARDIOPULMONARY BYPASS; DOGS; EXTRAVASCULAR LUNG WATER; GLYCINE; HEMODYNAMIC PROCESSES; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTE COUNT; LEUKOCYTE ELASTASE; LUNG; OXYGEN; PROTECTIVE AGENTS; PULMONARY CIRCULATION; REPERFUSION INJURY; SERINE PROTEINASE INHIBITORS; SULFONAMIDES; VASCULAR RESISTANCE;

EID: 0033377280     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00831-0     Document Type: Article

References (20)

1. Kambara K., Jerome E.H., Serikov V.B., et al. Reliability of extravascular lung thermal volume measurements by thermal conductivity technique in sheep. J Appl Physiol. 73:1992;1449-1456.
2. Kirklin J.K., Westaby S., Blackstone E.H., Kirklin J.W., Chenoweth D.E., Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 86:1983;845-857.
3. Hammerschmidt D.E., Stroncek D.F., Bowers T.K., et al. Complement activity and neutropenia occurring during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 81:1981;370-377.
4. Miller D.R., Kuenzig M.C. Pulmonary changes following normothermic and profound hypothermic perfusion in dog. J Thorac Cardiovasc Surg. 56:1968;717-731.
5. Asada S., Yamaguchi M. Fine structural change in the lung following cardiopulmonary bypass. Chest. 59:1971;478-483.
6. Anyanwu E., Dittrich H., Gieseking R., Enders H.J. Ultrastructural changes in the human lung following cardiopulmonary bypass. Basic Res Cardiol. 77:1982;309-322.
7. Kuratani T., Matsuda H., Sawa Y., Kaneko M., Nakano S., Kawashima Y. Experimental study in a rabbit of ischemia-reperfusion lung injury during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 103:1992;564-568.
8. Ohwada S., Tomizawa N., Takahashi T., et al. Effects of specific neutrophil elastase inhibitor (ONO-5046) and neutrophil depletion using a G-1 column on lung reperfusion injury in dogs. Transplantation. 28:1996;1826-1827.
9. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med. 320:1989;365-376.
10. Weiland J.E., Davis W.B., Holter J.F., Mohammed J.R., Dorinsky P.M., Gadek J.E. Lung neutrophils in the adult respiratory distress syndrome clinical and pathophysiologic significance . Am Rev Respir Dis. 133:1986;218-225.
11. Fowler A.A., Hyers T.M., Fisher B.J., Bechard R.M., Centor R.M., Webster R.O. The adult respiratory distress syndrome cell populations and soluble mediators in the air spaces of patients at high risk . Am Rev Respir Dis. 136:1987;1225-1231.
12. Kawabata K., Moore A.R., Willoughby D.A. Impaired activity of protease inhibitors towards neutrophil elastase bound to human articular cartilage. Ann Rheum Dis. 55:1996;248-252.
13. Kawabata K., Suzuki M., Sugitani M., Imaki K., Tada M., Miyamoto T. ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun. 177:1991;814-820.
14. Suzuki N., Ishii Y., Kitamura S. Mechanism for the increased permeability in endothelial monolayers induced by elastase. Mediators Inflamm. 3:1994;11-16.
15. Sakamaki F., Ishizaka A., Urano T., et al. Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury. Am J Respir Crit Care Med. 153:1996;391-397.
16. Kubo K., Kobayashi T., Hayano T., et al. Effects of ONO-5046, a specific neutrophil elastase inhibitor, on endotoxin-induced lung injury in sheep. J Appl Physiol. 77:1994;1333-1340.
17. Tamakuma S., Shiba T., Hirasawa H., et al. A phase III clinical study of a neutrophil elastase inhibitor, ONO-5046-Na in SIRS patients. Rinsho Iyaku. 14:1998;289-318.
18. Kawamura T., Wakusawa R., Okada K., Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass participation of interleukin 8 and 6 in reperfusion injury . Can J Anaesth. 40:1993;1016-1021.
19. Ito H., Hamano K., Gohra H., et al. Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today. 27:1997;220-225.
20. Usui A., Hiroura M., Kawamura M., et al. Nafamostat mesilate (FUT-175) reduces blood-foreign surface reactions similar to biocompatible materials. Ann Thorac Surg. 62:1996;1404-1411.